Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Madhuri T. Patil"'
Autor:
Aashima Batra, Manpreet Kaur, Deepender Kaushik, Simran Kaur, Madhuri T. Patil, Vinod D. Chaudhari, Subash Chandra Sahoo, Deepak B. Salunke
Publikováno v:
ACS Omega, Vol 9, Iss 27, Pp 29372-29378 (2024)
Externí odkaz:
https://doaj.org/article/a81b27a9e552482286f80555137bf3ad
Autor:
Ravinder Kumar, Rahul Singh, Ayla das Chagas Almeida, Juliana da Trindade Granato, Ari Sérgio de Oliveira Lemos, Kushvinder Kumar, Madhuri T. Patil, Adilson D. da Silva, Ambadas B. Rode, Elaine S. Coimbra, Deepak B. Salunke
Publikováno v:
ACS Omega, Vol 8, Iss 43, Pp 40613-40621 (2023)
Externí odkaz:
https://doaj.org/article/14f641b4f5ae417ea79873e880febaec
Autor:
Deepender Kaushik, Simran Dhingra, Madhuri T. Patil, Sakshi Piplani, Varun Khanna, Yoshikazu Honda-Okubo, Lei Li, Johnson Fung, Isaac G. Sakala, Deepak B. Salunke, Nikolai Petrovsky
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 8, Pp 1989-1996 (2020)
Better adjuvants are needed for vaccines against seasonal influenza. TLR7 agonists are potent activators of innate immune responses and thereby may be promising adjuvants. Among the imidazoquinoline compounds, 1-benzyl-2-butyl-1H-imidazo[4,5-c]quinol
Externí odkaz:
https://doaj.org/article/2cd2603c6eb1498d8e7b8399fcbe1589
Autor:
Rahul Singh, Ravinder Kumar, Manpreet Kaur, Madhuri T. Patil, Subash Chandra Sahoo, Deepak B. Salunke
Publikováno v:
Journal of Heterocyclic Chemistry. 59:1007-1015
Autor:
Kamal Nain Singh, Vinod D. Chaudhari, Kushvinder Kumar, Deepak B. Salunke, Madhuri T. Patil, Manpreet Kaur, Subash Chandra Sahoo, Rahul Singh
Publikováno v:
Journal of Heterocyclic Chemistry. 59:319-328
Autor:
Nitai Sarkar, Nivedita Tanaji Patil, Mysore S. Shashidhar, Rajesh G. Gonnade, Madhuri T. Patil
Publikováno v:
Crystal Growth & Design. 21:3786-3797
The crystal structure database was used to identify inositol derivatives that could be crystallizing as racemic conglomerates. Among the six racemic inositol derivatives identified, racemic 4-O-tosyl-6-O-benzyl-myo-inositol-1,3,5-orthoformate (A) was
Autor:
Lei Li, Deepak B. Salunke, Johnson Fung, Varun Khanna, Deepender Kaushik, Yoshikazu Honda-Okubo, Madhuri T. Patil, Isaac G. Sakala, Nikolai Petrovsky, Sakshi Piplani, Simran Dhingra
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Better adjuvants are needed for vaccines against seasonal influenza. TLR7 agonists are potent activators of innate immune responses and thereby may be promising adjuvants. Among the imidazoquinoline compounds, 1-benzyl-2-butyl-1H-imidazo[4,5-c]quinol
Publikováno v:
Physical Sciences Reviews.
Cancer weakens the immune system which fails to fight against the rapidly growing cells. Among the various types of cancers, prostate cancer (PCa) is causing greater number of deaths in men after lung cancer, demanding advancement to prevent, detect
Publikováno v:
RSC Advances. 8:9587-9596
Diacylated PAM2CSK4, a highly expensive lipopeptide with desirable aqueous solubility and a broad spectrum of cytokine/chemokine induction is a most potent dual (human and murine) Toll-Like Receptor-2 (TLR2) agonist. Besides such thrilling characteri